-+ 0.00%
-+ 0.00%
-+ 0.00%

Janux reclassifies Eric Dobmeier as Class II director, keeps him on compensation committee

PUBT·04/28/2026 21:08:32
Listen to the news
Janux reclassifies Eric Dobmeier as Class II director, keeps him on compensation committee
  • Janux Therapeutics reclassified board member Eric Dobmeier to Class II from Class III on April 28, 2026.
  • Dobmeier resigned from board to facilitate rebalancing of director classes.
  • Board immediately reappointed Dobmeier as Class II director with term expiring at 2026 annual meeting.
  • Dobmeier will continue serving on board Compensation Committee.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Janux Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-187641), on April 28, 2026, and is solely responsible for the information contained therein.